SHR-7631
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SHR-7631, covering 2025-06-13 to 2025-06-13. Get the full timeline:
Most recent: Clinical Trial Update: The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors [Phase 1]